Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR

Cancer Treatment Reviews - Tập 35 - Trang 262-271 - 2009
Volker Heinemann1, Sebastian Stintzing1, Thomas Kirchner1, Stefan Boeck1, Andreas Jung1
1Department of Hematology/Oncology, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, Marchionini-Street 15, 81377 Munich, Germany

Tài liệu tham khảo